TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive NCI To Lose 382 Cancer FTEs; DCE Board Gets Response From Sullivan, But No Promises July 21, 1989
TCL Archive New Technology May Enable Therapy Tailored To Patient’s Predicted Response April 26, 2002
TCL Archive DCPC Board Defers Decision On Hepatitis Vaccine Study, Rejects PAP Sensitivity Concepts June 1, 1984
TCL Archive New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial May 30, 2014
